Abstract:Reversible protein phosphorylation directs essential cellular processes including cell division, cell growth, cell death, inflammation, and differentiation. Because protein phosphorylation drives diverse diseases, kinases and phosphatases have been targets for drug discovery, with some achieving remarkable clinical success. Most protein kinases are activated by phosphorylation of their activation loops, which shifts the conformational equilibrium of the kinase towards the active state. To turn off the kinase, protein phosphatases dephosphorylate these sites, but how the conformation of the dynamic activation loop contributes to dephosphorylation was not known. To answer this, we modulated the activation loop conformational equilibrium of human p38α ΜΑP kinase with existing kinase inhibitors that bind and stabilize specific inactive activation loop conformations. From this, we discovered three inhibitors that increase the rate of dephosphorylation of the activation loop phospho-threonine by the PPM serine/threonine phosphatase WIP1. Hence, these compounds are "dual-action" inhibitors that simultaneously block the active site and stimulate p38α dephosphorylation. Our X-ray crystal structures of phosphorylated p38α bound to the dual-action inhibitors reveal a shared flipped conformation of the activation loop with a fully accessible phospho-threonine. In contrast, our X-ray crystal structure of phosphorylated apo human p38α reveals a different activation loop conformation with an inaccessible phospho-threonine, thereby explaining the increased rate of dephosphorylation upon inhibitor binding. These findings reveal a conformational preference of phosphatases for their targets and suggest a new approach to achieving improved potency and specificity for therapeutic kinase inhibitors.

Dynamic and structural insights into allosteric regulation on MKP5 a dual-specificity phosphatase

Structural and dynamic insights into the mechanism of allosteric signal transmission in ERK2-mediated MKP3 activation.

Structural Insights into the Enzymatic Mechanism of the Pathogenic MAPK Phosphothreonine Lyase.

Kinetic and mechanistic studies of p38α MAP kinase phosphorylation by MKK6.

A conserved motif in JNK/p38-specific MAPK phosphatases as a determinant for JNK1 recognition and inactivation

A distinct interaction mode revealed by the crystal structure of the kinase p38α with the MAPK binding domain of the phosphatase MKP5.

Mitogen-Activated Protein Kinase Phosphatase-1: A Critical Phosphatase Manipulating Mitogen-Activated Protein Kinase Signaling In Cardiovascular Disease

Post-translational regulation of mitogen-activated protein kinase phosphatase-2 (MKP-2) by ERK

Architecture of the MKK6-p38α complex defines the basis of MAPK specificity and activation

Conformational dynamics, energetics, and the divergent evolution of allosteric regulation: the case of the yeast MAPK family

Structural Insight into Mechanisms for Dynamic Regulation of PKM2.

Structural and mechanistic insights into Mps1 kinase activation.

Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3.

Allosteric inhibition of PPM1D serine/threonine phosphatase via an altered conformational state

Regulation of Innate and Adaptive Immune Responses by MAP Kinase Phosphatase 5

Microsecond Molecular Dynamics Simulations Provide Insight into the ATP-competitive Inhibitor-Induced Allosteric Protection of Akt Kinase Phosphorylation.

MAPK Phosphatase-5 is required for TGF-β signaling through a JNK-dependent pathway

Crystal Structure of the Phosphorylated Arabidopsis MKK5 Reveals Activation Mechanism of MAPK Kinases

Dual-Action Kinase Inhibitors Influence p38α MAP Kinase Dephosphorylation

Dynamics of Post-Translational Modification Inspires Drug Design in the Kinase Family

Discriminating between competing models for the allosteric regulation of oncogenic phosphatase SHP2 by characterizing its active state